Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Apellis Pharmaceuticals Inc (APLS) | XNAS | US | 2024-12-31 | 3 days ago | USD | 19.42 | 0.00 | 0.00% | 1.06 | 5.48% | Ungraded | 0.00 | 0.00% |
| 132 | Apyx Medical Corp (APYX) | XNAS | US | 2024-12-31 | 3 days ago | USD | 0.96 | 0.00 | 0.00% | 0.15 | 16.02% | Ungraded | 0.00 | 0.00% |
| 133 | Asta Funding Inc (ASFI) | 2019-09-30 | 4 years ago | USD | 0.00 | 10.73 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 3 days ago | USD | 3.56 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 3 days ago | USD | 1.15 | 0.00 | 0.00% | 0.57 | 49.33% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 3 days ago | USD | 2.91 | 0.00 | 0.00% | 1.86 | 63.89% | Ungraded | 0.00 | 0.00% |
| 139 | Digital Turbine Inc (APPS) | XNAS | US | 2024-03-31 | 3 days ago | USD | 2.74 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 3 days ago | USD | 0.22 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |